Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Intercell submits MAA for Japanese encephalitis vaccine

Intercell (VSE:ICLL) submitted an MAA to EMEA for

Read the full 85 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE